Catheter-based high-intensity ultrasound for epicardial ablation of the left ventricle: Device design and in vivo feasiblity

Vasant A. Salgaonkar, Babak Nazer, Peter D. Jones, Yasuaki Tanaka, Alastair Martin, Bennett Ng, Srikant Duggirala, Chris J. Diederich, Edward P. Gerstenfeld

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Abstract

The development and in vivo testing of a high-intensity ultrasound thermal ablation catheter for epicardial ablation of the left ventricle (LV) is presented. Scar tissue can occur in the mid-myocardial and epicardial space in patients with nonischemic cardiomyopathy and lead to ventricular tachycardia. Current ablation technology uses radiofrequency energy, which is limited epicardially by the presence of coronary vessels, phrenic nerves, and fat. Ultrasound energy can be precisely directed to deliver targeted deep epicardial ablation while sparing intervening epicardial nerve and vessels. The proof-of-concept ultrasound applicators were designed for sub-xyphoid access to the pericardial space through a steerable 14-Fr sheath. The catheter consists of two rectangular planar transducers, for therapy (6.4 MHz) and imaging (5 MHz), mounted at the tip of a 3.5-mm flexible nylon catheter coupled and encapsulated within a custom-shaped balloon for cooling. Thermal lesions were created in the LV in a swine (n = 10) model in vivo. The ultrasound applicator was positioned fluoroscopically. Its orientation and contact with the LV were verified using A-mode imaging and a radio-opaque marker. Ablations employed 60-s exposures at 15 - 30 W (electrical power). Histology indicated thermal coagulation and ablative lesions penetrating 8 - 12 mm into the left ventricle on lateral and anterior walls and along the left anterior descending artery. The transducer design enabled successful sparing from the epicardial surface to 2 - 4 mm of intervening ventricle tissue and epicardial fat. The feasibility of targeted epicardial ablation with catheter-based ultrasound was demonstrated.

Original languageEnglish (US)
Title of host publicationEnergy-Based Treatment of Tissue and Assessment VIII
PublisherSPIE
Volume9326
ISBN (Electronic)9781628414165
DOIs
StatePublished - 2015
Externally publishedYes
Event2015 SPIE Conference: Energy-Based Treatment of Tissue and Assessment - San Francisco, United States
Duration: Feb 8 2015Feb 9 2015

Other

Other2015 SPIE Conference: Energy-Based Treatment of Tissue and Assessment
CountryUnited States
CitySan Francisco
Period2/8/152/9/15

Fingerprint

Equipment Design
Catheters
Ablation
ablation
Heart Ventricles
Ultrasonics
Catheter Ablation
Hot Temperature
Transducers
Applicators
Fats
fats
nerves
Oils and fats
lesions
Phrenic Nerve
vessels
Pericardium
Nylons
transducers

Keywords

  • cardiac ablation
  • HIFU
  • image guidance
  • therapeutic ultrasound
  • ventricular tachycardia

ASJC Scopus subject areas

  • Atomic and Molecular Physics, and Optics
  • Electronic, Optical and Magnetic Materials
  • Biomaterials
  • Radiology Nuclear Medicine and imaging

Cite this

Salgaonkar, V. A., Nazer, B., Jones, P. D., Tanaka, Y., Martin, A., Ng, B., ... Gerstenfeld, E. P. (2015). Catheter-based high-intensity ultrasound for epicardial ablation of the left ventricle: Device design and in vivo feasiblity. In Energy-Based Treatment of Tissue and Assessment VIII (Vol. 9326). [93260H] SPIE. https://doi.org/10.1117/12.2079629

Catheter-based high-intensity ultrasound for epicardial ablation of the left ventricle : Device design and in vivo feasiblity. / Salgaonkar, Vasant A.; Nazer, Babak; Jones, Peter D.; Tanaka, Yasuaki; Martin, Alastair; Ng, Bennett; Duggirala, Srikant; Diederich, Chris J.; Gerstenfeld, Edward P.

Energy-Based Treatment of Tissue and Assessment VIII. Vol. 9326 SPIE, 2015. 93260H.

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Salgaonkar, VA, Nazer, B, Jones, PD, Tanaka, Y, Martin, A, Ng, B, Duggirala, S, Diederich, CJ & Gerstenfeld, EP 2015, Catheter-based high-intensity ultrasound for epicardial ablation of the left ventricle: Device design and in vivo feasiblity. in Energy-Based Treatment of Tissue and Assessment VIII. vol. 9326, 93260H, SPIE, 2015 SPIE Conference: Energy-Based Treatment of Tissue and Assessment, San Francisco, United States, 2/8/15. https://doi.org/10.1117/12.2079629
Salgaonkar VA, Nazer B, Jones PD, Tanaka Y, Martin A, Ng B et al. Catheter-based high-intensity ultrasound for epicardial ablation of the left ventricle: Device design and in vivo feasiblity. In Energy-Based Treatment of Tissue and Assessment VIII. Vol. 9326. SPIE. 2015. 93260H https://doi.org/10.1117/12.2079629
Salgaonkar, Vasant A. ; Nazer, Babak ; Jones, Peter D. ; Tanaka, Yasuaki ; Martin, Alastair ; Ng, Bennett ; Duggirala, Srikant ; Diederich, Chris J. ; Gerstenfeld, Edward P. / Catheter-based high-intensity ultrasound for epicardial ablation of the left ventricle : Device design and in vivo feasiblity. Energy-Based Treatment of Tissue and Assessment VIII. Vol. 9326 SPIE, 2015.
@inproceedings{64ceb124bc504e3a8299d8fefd281d59,
title = "Catheter-based high-intensity ultrasound for epicardial ablation of the left ventricle: Device design and in vivo feasiblity",
abstract = "The development and in vivo testing of a high-intensity ultrasound thermal ablation catheter for epicardial ablation of the left ventricle (LV) is presented. Scar tissue can occur in the mid-myocardial and epicardial space in patients with nonischemic cardiomyopathy and lead to ventricular tachycardia. Current ablation technology uses radiofrequency energy, which is limited epicardially by the presence of coronary vessels, phrenic nerves, and fat. Ultrasound energy can be precisely directed to deliver targeted deep epicardial ablation while sparing intervening epicardial nerve and vessels. The proof-of-concept ultrasound applicators were designed for sub-xyphoid access to the pericardial space through a steerable 14-Fr sheath. The catheter consists of two rectangular planar transducers, for therapy (6.4 MHz) and imaging (5 MHz), mounted at the tip of a 3.5-mm flexible nylon catheter coupled and encapsulated within a custom-shaped balloon for cooling. Thermal lesions were created in the LV in a swine (n = 10) model in vivo. The ultrasound applicator was positioned fluoroscopically. Its orientation and contact with the LV were verified using A-mode imaging and a radio-opaque marker. Ablations employed 60-s exposures at 15 - 30 W (electrical power). Histology indicated thermal coagulation and ablative lesions penetrating 8 - 12 mm into the left ventricle on lateral and anterior walls and along the left anterior descending artery. The transducer design enabled successful sparing from the epicardial surface to 2 - 4 mm of intervening ventricle tissue and epicardial fat. The feasibility of targeted epicardial ablation with catheter-based ultrasound was demonstrated.",
keywords = "cardiac ablation, HIFU, image guidance, therapeutic ultrasound, ventricular tachycardia",
author = "Salgaonkar, {Vasant A.} and Babak Nazer and Jones, {Peter D.} and Yasuaki Tanaka and Alastair Martin and Bennett Ng and Srikant Duggirala and Diederich, {Chris J.} and Gerstenfeld, {Edward P.}",
year = "2015",
doi = "10.1117/12.2079629",
language = "English (US)",
volume = "9326",
booktitle = "Energy-Based Treatment of Tissue and Assessment VIII",
publisher = "SPIE",

}

TY - GEN

T1 - Catheter-based high-intensity ultrasound for epicardial ablation of the left ventricle

T2 - Device design and in vivo feasiblity

AU - Salgaonkar, Vasant A.

AU - Nazer, Babak

AU - Jones, Peter D.

AU - Tanaka, Yasuaki

AU - Martin, Alastair

AU - Ng, Bennett

AU - Duggirala, Srikant

AU - Diederich, Chris J.

AU - Gerstenfeld, Edward P.

PY - 2015

Y1 - 2015

N2 - The development and in vivo testing of a high-intensity ultrasound thermal ablation catheter for epicardial ablation of the left ventricle (LV) is presented. Scar tissue can occur in the mid-myocardial and epicardial space in patients with nonischemic cardiomyopathy and lead to ventricular tachycardia. Current ablation technology uses radiofrequency energy, which is limited epicardially by the presence of coronary vessels, phrenic nerves, and fat. Ultrasound energy can be precisely directed to deliver targeted deep epicardial ablation while sparing intervening epicardial nerve and vessels. The proof-of-concept ultrasound applicators were designed for sub-xyphoid access to the pericardial space through a steerable 14-Fr sheath. The catheter consists of two rectangular planar transducers, for therapy (6.4 MHz) and imaging (5 MHz), mounted at the tip of a 3.5-mm flexible nylon catheter coupled and encapsulated within a custom-shaped balloon for cooling. Thermal lesions were created in the LV in a swine (n = 10) model in vivo. The ultrasound applicator was positioned fluoroscopically. Its orientation and contact with the LV were verified using A-mode imaging and a radio-opaque marker. Ablations employed 60-s exposures at 15 - 30 W (electrical power). Histology indicated thermal coagulation and ablative lesions penetrating 8 - 12 mm into the left ventricle on lateral and anterior walls and along the left anterior descending artery. The transducer design enabled successful sparing from the epicardial surface to 2 - 4 mm of intervening ventricle tissue and epicardial fat. The feasibility of targeted epicardial ablation with catheter-based ultrasound was demonstrated.

AB - The development and in vivo testing of a high-intensity ultrasound thermal ablation catheter for epicardial ablation of the left ventricle (LV) is presented. Scar tissue can occur in the mid-myocardial and epicardial space in patients with nonischemic cardiomyopathy and lead to ventricular tachycardia. Current ablation technology uses radiofrequency energy, which is limited epicardially by the presence of coronary vessels, phrenic nerves, and fat. Ultrasound energy can be precisely directed to deliver targeted deep epicardial ablation while sparing intervening epicardial nerve and vessels. The proof-of-concept ultrasound applicators were designed for sub-xyphoid access to the pericardial space through a steerable 14-Fr sheath. The catheter consists of two rectangular planar transducers, for therapy (6.4 MHz) and imaging (5 MHz), mounted at the tip of a 3.5-mm flexible nylon catheter coupled and encapsulated within a custom-shaped balloon for cooling. Thermal lesions were created in the LV in a swine (n = 10) model in vivo. The ultrasound applicator was positioned fluoroscopically. Its orientation and contact with the LV were verified using A-mode imaging and a radio-opaque marker. Ablations employed 60-s exposures at 15 - 30 W (electrical power). Histology indicated thermal coagulation and ablative lesions penetrating 8 - 12 mm into the left ventricle on lateral and anterior walls and along the left anterior descending artery. The transducer design enabled successful sparing from the epicardial surface to 2 - 4 mm of intervening ventricle tissue and epicardial fat. The feasibility of targeted epicardial ablation with catheter-based ultrasound was demonstrated.

KW - cardiac ablation

KW - HIFU

KW - image guidance

KW - therapeutic ultrasound

KW - ventricular tachycardia

UR - http://www.scopus.com/inward/record.url?scp=84930427494&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930427494&partnerID=8YFLogxK

U2 - 10.1117/12.2079629

DO - 10.1117/12.2079629

M3 - Conference contribution

AN - SCOPUS:84930427494

VL - 9326

BT - Energy-Based Treatment of Tissue and Assessment VIII

PB - SPIE

ER -